18 Biggest Mid-Day Losers For Tuesday

EnteroMedics Inc ETRM shares dropped 24 percent to $4.64 after the company reported its earnings for the three-month period ending March 31, 2017, and an overview of its recent commercialization and corporate achievements. During the quarter, the company reported sales of $40,000 with gross profits totaling $11,000. Net loss for the quarter totaled $7.4 million while the company ended the period with cash, cash equivalents and short-term investments of $18.7 million.
Bovie Medical Corporation BVX shares dipped 23.8 percent to $2.02. Bovie Medical reported a Q1 loss of $0.06 per share on sales of $8.4 million.
Mirna Therapeutics Inc MIRN shares tumbled 20.2 percent to $1.62. Synlogic and Mirna Therapeutics agreed to merge in an all-stock deal.
Pernix Therapeutics Holdings Inc PTX fell 18.2 percent to $4.69. Pernix Therapeutics reported a Q1 loss of $2.94 per share on revenue of $29.742 million.
ImmunoCellular Therapeutics Ltd IMUC shares declined 16 percent to $1.31. ImmunoCellular Therapeutics reported a Q1 loss of $1.64 per share.
Xenetic Biosciences Inc XBIO fell 15.6 percent to $2.70 as the company posted a wider-than-expected quarterly loss.
Virtusa Corporation VRTU declined 14.8 percent to $27.61 on downbeat Q4 results.
VOXX International Corp VOXX shares dipped 13.4 percent to $6.15 after the company posted weak quarterly results.
TearLab Corp TEAR declined 11.5 percent to $2.30 after the company posted disappointing quarterly results.
Akers Biosciences Inc AKER dropped 11.4 percent to $1.55. Akers Biosciences posted Q1 net loss attributable to shareholders of $1,349,270, and revenue $667,250.
Fate Therapeutics Inc FATE shares fell 11.2 percent to $3.65 as the company posted a bigger-than-expected Q1 loss.
Dicks Sporting Goods Inc DKS shares declined 10.8 percent to $42.47. Dicks posted in-line quarterly earnings but same-store sales missed estimates. UBS downgraded Dick's from Buy to Hold.
Viewray Inc VRAY dropped 10 percent to $6.30. ViewRay reported a Q1 loss of $28 million on sales of $1.2 million.
Forterra Inc FRTA tumbled 9.6 percent to $13.50. RBC Capital downgraded Forterra from Outperform to Sector Perform, while SunTrust Robinson Humphrey downgraded the stock from Buy to Hold.
Capricor Therapeutics Inc CAPR fell 9.3 percent to $1.08 on wider-than-expected quarterly loss.
Staples, Inc. SPLS declined 4.8 percent to $8.87. Staples posted upbeat profit for its first quarter, but sales missed expectations.
Stratasys, Ltd. SSYS declined 3 percent to $29.04. Stratasys posted in-line quarterly earnings.
M.D.C. Holdings, Inc. MDC fell 3 percent to $34.56. Wells Fargo downgraded M.D.C. from Market Perform to Underperform.